Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4340  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: Preliminary study

Shinde Santosh, Pasupathy K

Year : 2006| Volume: 54| Issue : 4 | Page no: 390-393

   This article has been cited by
 
1 Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders
Slawomir Michalak,Jolanta Florczak-Wyspianska,Joanna Rybacka-Mossakowska,Wojciech Ambrosius,Krystyna Osztynowicz,Aleksandra Baszczuk,Wojciech Kozubski,Ewa Wysocka
Oxidative Medicine and Cellular Longevity. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
2 Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinsonæs disease
Dharmendra K. Khatri,Archana R. Juvekar
Pharmacology Biochemistry and Behavior. 2016; 150-151: 39
[Pubmed]  [Google Scholar] [DOI]
3 Somatic mtDNA variation is an important component of Parkinsonæs disease
Jonathan Coxhead,Marzena Kurzawa-Akanbi,Rafiqul Hussain,Angela Pyle,Patrick Chinnery,Gavin Hudson
Neurobiology of Aging. 2016; 38: 217.e1
[Pubmed]  [Google Scholar] [DOI]
4 Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
Gerwyn Morris,Michael Berk,Ken Walder,Michael Maes
BMC Medicine. 2015; 13(1): 28
[Pubmed]  [Google Scholar] [DOI]
5 The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris,Michael Berk
BMC Medicine. 2015; 13(1)
[Pubmed]  [Google Scholar] [DOI]
6 Lymphocyte vitamin C level as a potential biomarker for the progression of Parkinson’s disease
Kazuki Ide,Hiroshi Yamada,Keizo Umegaki,Katsuki Mizuno,Nobuko Kawakami,Yuka Hagiwara,Mizuki Matsumoto,Hidefumi Yoshida,Kang Kim,Emi Shiosaki,Tsunehiro Yokochi,Kiyoshi Harada
Nutrition. 2014;
[Pubmed]  [Google Scholar] [DOI]
7 G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson’s Disease Patients
Noemí Esteras,Carolina Alquézar,Fernando Bartolomé,Ana de la Encarnación,Félix Bermejo-Pareja,José Antonio Molina,Ángeles Martín-Requero
Molecular Neurobiology. 2014;
[Pubmed]  [Google Scholar] [DOI]
8 Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinsonæs disease
Eugénie Mutez,Aurore Nkiliza,Karim Belarbi,Amélie De Broucker,Christel Vanbesien-Mailliot,Séverine Bleuse,Aurélie Duflot,Thomas Comptdaer,Pierre Semaille,Renaud Blervaque,David Hot,Frederic Leprêtre,Martin Figeac,Alain Destée,Marie-Christine Chartier-Harlin
Neurobiology of Disease. 2013;
[Pubmed]  [Google Scholar] [DOI]
9 LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: Implications for mitochondrial dysfunction associated with Parkinsonæs disease
Yulia Y. Tyurina,Daniel E. Winnica,Valentina I. Kapralova,Alexandr A. Kapralov,Vladimir A. Tyurin,Valerian E. Kagan
Molecular Nutrition & Food Research. 2013; 57(8): 1410
[Pubmed]  [Google Scholar] [DOI]
10 Mitochondrial Diseases of the Brain
Rajnish K. Chaturvedi,M. Flint Beal
Free Radical Biology and Medicine. 2013; 63: 1
[Pubmed]  [Google Scholar] [DOI]
11 The Bad, the Good, and the Ugly about Oxidative Stress
Marlene Jimenez-Del-Rio,Carlos Velez-Pardo
Oxidative Medicine and Cellular Longevity. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]
12 The bad, the good, and the ugly about oxidative stress
Jimenez-Del-Rio, M. and Velez-Pardo, C.
Oxidative Medicine and Cellular Longevity. 2012; (163913)
[Pubmed]  [Google Scholar]
13 DNA methylation as a biomarker for neuropsychiatric diseases
Sanxi Ai, Lu Shen, Jifeng Guo, Xiang Feng, Beisha Tang
International Journal of Neuroscience. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
14 OXPHOS toxicogenomics and Parkinsonæs disease
Ester López-Gallardo, Ruth Iceta, Eldris Iglesias, Julio Montoya, Eduardo Ruiz-Pesini
Mutation Research/Reviews in Mutation Research. 2011;
[HTML Full text]  [Google Scholar] [DOI]
15 Mitochondrial dysfunction in Parkinsonæs disease
Keane, P.C., Kurzawa, M., Blain, P.G., Morris, C.M.
Parkinsonæs Disease. 2011; : art 716871
[Pubmed]  [Google Scholar]
16 Oxidative stress in skin fibroblasts cultures from patients with Parkinsonæs disease
del Hoyo, P., García-Redondo, A., de Bustos, F., Molina, J.A., Sayed, Y., Alonso-Navarro, H., Caballero, L., (...), Jiménez-Jiménez, F.J.
BMC Neurology. 2010; 10: art 05
[Pubmed]  [Google Scholar]
17 Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation
Neurobiology of Aging. 2010;
[HTML Full text]  [Google Scholar] [DOI]
18 Mitochondrial proteomics as a selective tool for unraveling Parkinsons disease pathogenesis
Pienaar, I.S., Dexter, D.T., Burkhard, P.R.
Expert Review of Proteomics. 2010; 7(2): 205-226
[Pubmed]  [Google Scholar]
19 When does Parkinson disease start?
Savica, R. and Rocca, W.A. and Ahlskog, J.E.
Archives of Neurology. 2010; 67(7): 798-801
[Pubmed]  [Google Scholar]
20 Oxidative stress in skin fibroblasts cultures from patients with Parkinsonæs disease
Pilar del Hoyo,Alberto García-Redondo,Fernando de Bustos,José Antonio Molina,Youssef Sayed,Hortensia Alonso-Navarro,Luis Caballero,Joaquín Arenas,José AG Agúndez,Félix Javier Jiménez-Jiménez
BMC Neurology. 2010; 10(1)
[Pubmed]  [Google Scholar] [DOI]
21 Mitochondrial proteomics as a selective tool for unraveling Parkinson’s disease pathogenesis
Ilse Sanet Pienaar,David Trevor Dexter,Pierre Roland Burkhard
Expert Review of Proteomics. 2010; 7(2): 205
[Pubmed]  [Google Scholar] [DOI]
22 Lesions outside the CNS in Parkinsonæs disease
Ruth Djaldetti, Nirit Lev, Eldad Melamed
Movement Disorders. 2009; 24(6): 793-800
[Pubmed]  [Google Scholar] [DOI]
23 Mitochondrial dysfunction in the limelight of Parkinsonæs disease pathogenesis
Rebecca Banerjee,Anatoly A. Starkov,M. Flint Beal,Bobby Thomas
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2009; 1792(7): 651
[Pubmed]  [Google Scholar] [DOI]
24 Mitochondrial dysfunction in the limelight of Parkinsonæs disease pathogenesis
Banerjee, R., Starkov, A.A., Beal, M.F., Thomas, B.
Biochimica et Biophysica Acta - Molecular Basis of Disease. 2009; 1792(7): 651-663
[Pubmed]  [Google Scholar]
25 Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinsonæs disease, but not Parkinson plus patients, from an Indian population
Varghese, M., Pandey, M., Samanta, A., Gangopadhyay, P.K., Mohanakumar, K.P.
Journal of the Neurological Sciences. 2009; 279(1-2): 39-42
[Pubmed]  [Google Scholar]
26 Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinsonæs disease, but not Parkinson plus patients, from an Indian population
Merina Varghese,Mritunjay Pandey,Ananda Samanta,Prasanta Kumar Gangopadhyay,Kochupurackal P. Mohanakumar
Journal of the Neurological Sciences. 2009; 279(1-2): 39
[Pubmed]  [Google Scholar] [DOI]
27 Efflux of Iron from the Cerebrospinal Fluid to the Blood at the Blood-CSF Barrier: Effect of Manganese Exposure
Xueqian Wang,G. Jane Li,Wei Zheng
Experimental Biology and Medicine. 2008; 233(12): 1561
[Pubmed]  [Google Scholar] [DOI]
28 Efflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier:Effect of manganese exposure
Wang, X., Li, G.J., Zheng, W.
Experimental Biology and Medicine. 2008; 233(12): 1561-1571
[Pubmed]  [Google Scholar]
29 Mitochondrial complex-1 in Parkinsonæs disease
Khan, S.Z.
Neurology India. 2006; 54(4): 351
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow